80 related articles for article (PubMed ID: 16779969)
1. A tumor-targeted nanodelivery system to improve early MRI detection of cancer.
Pirollo KF; Dagata J; Wang P; Freedman M; Vladar A; Fricke S; Ileva L; Zhou Q; Chang EH
Mol Imaging; 2006; 5(1):41-52. PubMed ID: 16779969
[TBL] [Abstract][Full Text] [Related]
2. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
3. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
[TBL] [Abstract][Full Text] [Related]
4. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts.
Shan L; Wang S; Sridhar R; Bhujwalla ZM; Wang PC
Mol Imaging; 2007; 6(2):85-95. PubMed ID: 17445503
[TBL] [Abstract][Full Text] [Related]
5. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
7. Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model.
Kaida S; Cabral H; Kumagai M; Kishimura A; Terada Y; Sekino M; Aoki I; Nishiyama N; Tani T; Kataoka K
Cancer Res; 2010 Sep; 70(18):7031-41. PubMed ID: 20685894
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery.
Pirollo KF; Zon G; Rait A; Zhou Q; Yu W; Hogrefe R; Chang EH
Hum Gene Ther; 2006 Jan; 17(1):117-24. PubMed ID: 16409130
[TBL] [Abstract][Full Text] [Related]
9. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
10. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM
Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005
[TBL] [Abstract][Full Text] [Related]
11. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
12. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
13. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
Hwang TL; Lee WR; Hua SC; Fang JY
J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
[TBL] [Abstract][Full Text] [Related]
15. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy.
Sun Y; Chen ZL; Yang XX; Huang P; Zhou XP; Du XX
Nanotechnology; 2009 Apr; 20(13):135102. PubMed ID: 19420486
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
17. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
[TBL] [Abstract][Full Text] [Related]
18. Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases.
Freedman M; Chang EH; Zhou Q; Pirollo KF
Acad Radiol; 2009 May; 16(5):627-37. PubMed ID: 19345904
[TBL] [Abstract][Full Text] [Related]
19. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.
Hamzah J; Altin JG; Herringson T; Parish CR; Hämmerling GJ; O'Donoghue H; Ganss R
J Immunol; 2009 Jul; 183(2):1091-8. PubMed ID: 19561111
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]